Cite
HARVARD Citation
Napoli, C. et al. (n.d.). Fixed-dose combination of zofenopril plus hydrochlorothiazide vs. irbesartan plus hydrochlorothiazide in hypertensive patients with established metabolic syndrome uncontrolled by previous monotherapy. The ZAMES study (Zofenopril in Advanced MEtabolic Syndrome). Journal of hypertension. 34 (11), pp. 2287-2297. [Online].